Since Afrezza can be used to 'normalize' a diabetic's blood glucose after every meal, it seems a crime to have to continue to administer a basal insulin to study subjects at all. Monomeric insulin has always been the solution to controlling diabetics' blood sugars.

Perhaps that day will arrive as the majority of diabetics are released from their basal insulin chains, and Afrezza becomes the gold standard.